Skip to main content
Erschienen in: Obesity Surgery 9/2017

Open Access 13.04.2017 | Original Contributions

Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014

verfasst von: L. Angrisani, A. Santonicola, P. Iovino, A. Vitiello, N. Zundel, H. Buchwald, N. Scopinaro

Erschienen in: Obesity Surgery | Ausgabe 9/2017

Abstract

Background and aim

Several bariatric surgery worldwide surveys have been previously published to illustrate the evolution of bariatric surgery in the last decades. The aim of this survey is to report an updated overview of all bariatric procedures performed in 2014.For the first time, a special section on endoluminal techniques was added.

Methods

The 2014 International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) survey form evaluating the number and the type of surgical and endoluminal bariatric procedures was emailed to all IFSO societies. Trend analyses from 2011 to 2014 were also performed.

Results

There were 56/60 (93.3%) responders. The total number of bariatric/metabolic procedures performed in 2014 consisted of 579,517 (97.6%) surgical operations and 14,725 (2.4%) endoluminal procedures. The most commonly performed procedure in the world was sleeve gastrectomy (SG) that reached 45.9%, followed by Roux-en-Y gastric bypass (RYGB) (39.6%), and adjustable gastric banding (AGB) (7.4%). The annual percentage changes from 2013 revealed the increase of SG and decrease of RYGB in all the IFSO regions (USA/Canada, Europe, and Asia/Pacific) with the exception of Latin/South America, where SG decreased and RYGB represented the most frequent procedure.

Conclusions

There was a further increase in the total number of bariatric/metabolic procedures in 2014 and SG is currently the most frequent surgical procedure in the world. This is the first survey that describes the endoluminal procedures, but the accuracy of provided data should be hopefully improved in the next future. We encourage the creation of further national registries and their continuous updates taking into account all new bariatric procedures including the endoscopic procedures that will obtain increasing importance in the near future.
Hinweise
An erratum to this article is available at https://​doi.​org/​10.​1007/​s11695-017-2773-8.
This comment refers to the article available at: https://​doi.​org/​10.​1007/​s11695-017-2681-y.

Introduction

All bariatric procedures currently available are actually considered effective in the treatment of morbid obesity and its related comorbidities compared to non-surgical interventions [1, 2]. The choice of one bariatric procedure over another is generally influenced by a number of factors such as literature results, specific local conditions, and the experience of the surgical staff in each country. Several bariatric surgery worldwide surveys have been previously published [36] to illustrate the evolution of bariatric surgery around the world in the last decades. Recently, we have published a global overview describing the number and type of each performed procedure of worldwide bariatric surgery in 2013 [7], together with the trends for the most important procedures during the 2003–2013 decade. Our data showed that sleeve gastrectomy (SG) had a steep increase all around the world, although Roux-en-Y gastric bypass (RYGB) still represented the most performed procedure, while adjustable gastric banding (AGB) declined.
During the last years, different endoluminal procedures (Orbera/BIB, Obalon, Spatz adjustable balloon system, heliosphere bag, primary obesity surgery endolumenal (POSE), stomaphix, Apollo, overstiches, endobarrier) have gained popularity among bariatric surgeons in the attempt to fill the gap between medical and surgical treatment for borderline patients [8].
Our aim in this survey is to report an updated overview of all bariatric procedures performed in the nations of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) in 2014. For the first time, in the 2014 IFSO survey, a special section on endoluminal techniques was added. Moreover, we chose the definition “mini-gastric bypass/one anastomosis gastric bypass (MGB/OAGB)”, as suggested by other authors [9, 10], in an attempt to reduce the heterogeneity in definitions that could generate a loss of accuracy in the reported data.

Methods

Survey

The IFSO Secretariat asked the national societies to provide data on the surgical techniques utilized by filling-out the 2014 survey form (Table 1). Each national society returned the data collected from its members, in some cases asking for information from each member of the society, and, in other cases, providing the information directly from a national registry.
Table 1
Questionnaire
https://static-content.springer.com/image/art%3A10.1007%2Fs11695-017-2666-x/MediaObjects/11695_2017_2666_Tab1_HTML.gif

Data Analysis

The relative prevalence of specific procedures is provided as weighted averages to account for the wide ranges in the number of procedures performed by the different IFSO member nations or national groupings. These data were used to estimate the annual percentage changes from 2013 [7].

Results

Response Rate

Sixty national bariatric societies or groups were contacted; among them 56 (93.3%) answered and provided a response form. Twenty had a national registry. Figure 1 depicts the completeness of data that each responding society declared, expressed as percentages.

Number and Type of Procedures

The total number of bariatric/metabolic procedures performed in 2014 consisted of 579,517 (97.6%) surgical operations and 14,725 (2.4%) endoluminal procedures. Tables 2 and 3 show the total number of each bariatric/metabolic surgical procedure together with the percentage of the most commonly performed such as sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), adjustable gastric banding (AGB), mini-gastric bypass/one anastomosis gastric bypass (MGB/OAGB), biliopancreatic diversion/ duodenal switch (BPD/DS), and the total number of each endoluminal procedure.
Table 2
Total number and percentage of bariatric/metabolic surgical procedures performed worldwide in 2014
Procedures
Number
Percentage
Sleeve gastrectomy (SG)
265,898
45.9
Roux-en-Y gastric bypass (RYGB)
229,455
39.6
Adjustable gastric banding (AGB)
42,388
7.4
Mini-gastric bypass/one anastomosis gastric bypass (MGB/OAGB)
10,403
1.8
Biliopancreatic diversion/ duodenal switch (BPD/DS)
6123
1.1
Miscellanea
25,250
4.3
Total
579,517
100
Table 3
Total number and percentage of endoluminal procedures performed worldwide in 2014
Procedures
Number
Percentage
Orbera/BIB
1664
11.6
Obalon
741
5.2
Spatz adjustable balloon system
62
0.4
Heliosphere bag
7
0.05
POSE
25
0.2
Apollo
6
0.04
Endobarrier
112
0.8
Not specified
11,658
81.6
Total
14,275
100
Overall total population of the 56 IFSO nations or national groupings in 2014 was estimated as 3,264,082,824 [11], so the 579,517-bariatric/metabolic surgical procedures performed account for 0.02% of the total population.
Table 4 showed the bariatric/metabolic surgical procedures and the endoluminal procedures performed in the four IFSO regions of the world: USA/Canada, Europe, Latin/South America, and Asia/Pacific.
Table 4
The bariatric/metabolic surgical procedures and the endoluminal procedures performed in the four IFSO regions of the world: USA/Canada, Europe, Latin/South America, and Asia/Pacific
Country
Total
AGB
RYGB
SG
BPD/DS
GP
MGB/OAGB
Other
Endoluminal procedures
North America
 Canada
6.522
702
3.158
2.362
300
0
0
0
0
 U.S.A.
191.920
18.500
59.124
113.381
886
29
0
0
0
Total per area
198.442
19.202
62.282
115.743
1.186
29
0
0
0
Europe
 Austria
2.553
91
1.418
521
4
496
0
23
18
 Azerbaijan
16
0
1
14
0
1
0
0
 
 Belgium
12.000
1.000
5.500
4.000
0
1.500
0
0
 
 Czech Republic
1.448
280
90
150
50
8
670
200
220
 Egypt
10.340
180
1.500
3.100
40
800
200
4.520
1200
 Finland
839
0
694
139
4
0
0
2
 
 France
46.960
4.364
14.015
28.581
0
0
0
0
 
 Germany
7.298
133
3.332
3.681
9
131
9
3
 
 Greece
1.327
110
85
756
8
275
65
28
10
 Iceland
163
108
52
3
0
0
0
0
 
 Israel
8881
659
877
7262
65
 
0
18
 
 Italy
8867
2182
1628
3799
124
477
268
389
 
 Lebanon*
         
 Lithuania
252
63
103
6
0
0
68
12
12
 Netherlands
8350
77
6757
1158
10
44
0
304
80
 Norway
3002
 
1653
1316
30
3
0
0
 
 Poland
2531
318
492
1334
1
207
0
179
179
 Portugal
2892
94
1290
986
54
260
9
199
 
 Romania
1380
27
99
1128
11
22
39
54
17
 Russian Federation
1621
419
118
861
71
29
7
116
77
 Serbia*
         
 Slovenia
200
3
31
26
0
115
0
25
 
 South Africa
566
0
423
63
68
0
0
12
 
 Spain
4030
126
1562
1839
142
34
27
300
 
 Sweden
6607
2
5386
1090
47
0
4
78
39
 Switzerland
4167
17
3173
646
41
17
0
273
 
 Turkey
6347
200
1350
3520
125
818
60
274
100
 Ukraine
251
2
30
91
47
13
27
41
18
 United Kingdom
6391
823
3011
2012
13
0
0
532
198
Total per area
149.279
11.278
54.670
68.082
964
5.250
1.453
7.582
2.168
Latin America
 Argentina
36.668
0
25.520
8.754
2.227
35
0
132
132
 Bolivia
314
0
92
174
0
2
36
10
 
 Brazil
97.480
450
66.000
20.200
1.050
600
30
9.150
8600
 Chile
5.311
3
1.133
3.814
0
0
3
358
196
 Colombia
12.700
4.800
7.200
0
50
150
0
500
500
 Costa Rica
1.448
280
90
150
50
8
670
200
220
 Dominican Republic
1.117
0
29
981
7
38
20
42
8
 Ecuador
626
0
80
150
3
40
10
343
30
 Guatemala
200
2
68
112
0
0
8
10
10
 Mexico*
         
 Panama*
         
 Paraguay
300
0
300
0
0
0
0
0
 
 Perù*
         
 Venezuela
4.472
11
2.880
1.498
3
0
0
80
 
Total per area
160.636
5.546
103.392
35.833
3.390
873
777
10.825
9.696
Asia/Pacific
 Australia—New Zeland
15.136
3.604
1.019
10.227
31
  
255
 
 China
4.195
50
1.866
2.229
0
0
20
30
 
 Hong Kong
144
2
4
116
1
1
1
19
17
 India
11.336
12
1.833
7.638
28
1.537
12
276
22
 Japan
222
4
20
144
54
0
0
0
 
 Korea
889
439
134
166
0
0
43
107
 
 Kuwait
5.498
244
61
3.803
4
22
0
1.364
1356
 Saudi Arabia
15.571
1.215
3.033
8.649
500
1.580
300
294
294
 Singapore
299
2
103
193
0
0
0
1
1
 Taiwan
2.421
31
119
1.484
0
194
21
572
34
 UEA
4033
170
262
3223
0
230
0
148
87
Total per area
59.744
5.773
8.454
37.872
618
3.564
397
3.066
1.811
*Not received
Nine nations or national grouping reported more than 10,000 bariatric/metabolic surgical procedures: USA (n = 191.920), Brazil (n = 97.480), France (n = 46.960), Argentina (n = 36.668), Saudi Arabia (n = 15.571), Australia—New Zeeland (n = 14.966), Colombia (n = 12.700), Belgium (n = 12.000) and India (n = 11.336). Kuwait’s total population has the world’s highest rate of bariatric/metabolic surgical procedures (0.28%) (Table 5). Kuwait also reported the highest number of endoluminal procedures of the Asia/Pacific Chapter (n = 1356). Among the nations of the European Chapter, the highest number of endoluminal interventions was performed in Egypt (n = 1200), while in Latin/South America, the largest number was reported by Brazil (n = 8600). USA/Canada did not report any endoluminal procedures (Table 4).

Worldwide

The annual percentage changes from 2013 of the worldwide bariatric/metabolic surgical procedures revealed that SG had the largest average annual percentage increase of approximately 9%; RYGB and AGB decreased, approximately 5 and 2.6%, respectively. MGB/OAGB and BPD/DS plateaued. Figure 2 presents the short-term trend in the world’s main bariatric/metabolic surgical procedures (SG, RYGB, AGB, MGB/OAGB, and BPD/DS) expressed as the relative proportion at the fixed intervals 2011–2013–2014.
Previous surveys did not report any data on endoluminal procedures, so the annual percentage changes or the time trend for these procedures were not calculated.

USA/Canada

The annual percentage changes from 2013 in USA/Canada revealed a further increase in the number of SG (+15.3%) that was consistent with the previous survey [7] and the slight decrease of RYGB (−3.9%). AGB and BPD/DS plateaued. Data on MGB/OAGB were not reported. Figure 3 shows the short-term trend of the main bariatric/metabolic surgical procedures (SG, RYGB, AGB, and BPD/DS) in USA/Canada expressed as the relative proportion at the fixed intervals 2011–2013–2014.

Europe

The annual percentage changes from 2013 in Europe revealed a steep increase in SG (+10.7%) and a slight decrease of RYGB (−3%). Also AGB, MGB/OAGB, and BPD/DS decreased (−7.5, −1.8, and −0.7%, respectively). Figure 4 shows the short-term trend of the main bariatric/metabolic surgical procedures (SG, RYGB, AGB, MGB/OAGB, and BPD/DS) in Europe expressed as the relative proportion at the fixed intervals 2011–2013–2014.

Latin/South America

The annual percentage changes from 2013 in Latin/South America revealed that the RYGB plateaued and represented the most frequently performed procedure; SG decreased, approximately 2.9%. AGB, MGB/OAGB and BPD/DS showed a plateauing. Figure 5 shows the short-term trend of the main bariatric/metabolic surgical procedures (SG, RYGB, AGB, MGB/OAGB, and BPD/DS) in Latin/South America expressed as the relative proportion at the fixed intervals 2011–2013–2014.

Asia/Pacific

The annual percentage changes from 2013 in Asia/Pacific revealed an increase of SG and MGB/OAGB, approximately 11 and 2.7%, respectively; RYGB and AGB decreased (−11.2 and 4.7%, respectively). BPD/DS plateaued. Figure 6 shows the short-term trend of the main bariatric/metabolic surgical procedures (SG, RYGB, AGB, MGB/OAGB, and BPD/DS) in Asia/Pacific expressed as the relative proportion at the fixed intervals 2011–2013–2014.

Discussion

This survey gives an updated description of bariatric procedures performed worldwide in 2014 and, for the first time, shows the worldwide incidence of endoluminal procedures such as Orbera/BIB, Obalon, Spatz adjustable balloon system, heliosphere bag, POSE, stomaphix, Apollo overstiches, and endobarrier.
This collected data reveal a further worldwide increase in the total number of bariatric/metabolic procedures in 2014 and demonstrate that SG in 2014 became the commonest bariatric procedure performed in the world. The strength of this survey compared to the previous one performed in 2013 was the higher response rate (93.3 vs 90.7%) that demonstrated a further increase of the bariatric/metabolic procedures declared in 2014 (+23%) [7]. Even more interestingly, SG has become the most frequently performed procedure in the world and has overtaken RYGB, which remains the most performed bariatric/metabolic procedure only in Latin/South America. As we have already hypothesized in our previous survey [7] the simpler surgical technique of SG compared to RYGB, together with the promising long-term weight loss outcomes [12, 13], could explain this result.
This survey also shows the short-term trend, from 2011 to 2014, of MGB/OAGB. Rutledge published the first experience on MGB/OAGB in 2001 [14]; it was subsequently performed around the world and several studies supported its efficacy and safety [15]. However, the worldwide MGB/OAGB trend reveals plateauing, with the exception of Asia/Pacific, the only region where MGB/OAGB increased. The current report on the number of MGB/OAGB could be underestimated considering that USA/Canada did not provide any data. Remarkably, the MGB/OAGB prevalence has not been reported not even in the last published estimation of bariatric procedures in the USA carried out by the American Society for Metabolic and Bariatric Surgery (ASMBS) [16].
Another strength of this survey is that we describe for the first time the endoluminal procedures performed in the world. The endoluminal interventions have gained popularity among bariatric surgeons and may be an appealing alternative to a wide group of patients who refuse bariatric surgery because of concerns about potential risks and complications or who were not eligible for bariatric surgery according to the current guidelines. On the other hand, for most of these new technologies, there are currently limited literature data, often based on small series [8] and there are no clinical guidelines. According to our data collection, 14,275 endoluminal procedures have been performed during 2014, but the real number is probably higher. Unfortunately many national databases are still lacking with information on endoluminal procedures. Therefore, we strongly recommend each society to endeavor to report as accurate data as possible.
In an attempt to improve the accuracy of our data, we contacted the manufacturers of the endoluminal devices. They declared a higher number of utilized devices compared to that reported by the IFSO nations. In fact, during 2014, Allergan BioEnterics stated that they have sold 25,043 Orbera/BIB, 953 Apollo endosurgery overstitch, 2935 medical implant helioscopie heliosphere, 5500 POSE, respectively. GI dynamics was not able to provide any data, however, they answered that 2900 endobarriers have been distributed since 2009. Obalon was removed from the market in 2014. Thus, the number of endoluminal procedures performed in 2014 is higher compared to those reported by IFSO nations and we believe that also the number of total bariatric procedures actually performed in the world is greater. Furthermore, the endoscopic and surgical procedures executed in private healthcare were not usually reported.
Table 5
Total population and number of procedures per country
Country
Total population
Total procedures per country
% of procedures for total population
North America
 USA—Canada
234,333,465
198.442
0.08
Total per area
234,333,465
198.442
0.08
EUROPE
 Austria
5,525,965
2.553
0.05
 Azerbaijan
6,881,963
16
0.00
 Belgium
6,836,150
12.000
0.18
 Czech Republic
7,181,452
1.448
0.02
 Egypt
54,652,669
8.140
0.01
 Finland
3,393,294
839
0.02
 France
41,728,824
46.960
0.11
 Germany
53,375,007
7.296
0.01
 Greece
7,077,088
1.315
0.02
 Iceland
212,047
163
0.08
 Israel
4,886,589
8.869
0.18
 Italy
40,232,892
8.787
0.02
 Jordan
4,780,143
7.407
0.15
 Kazakhstan
12,195,673
114
0.00
 Lithuania
2,435,496
252
0.01
 Netherlands
11,059,026
8.350
0.08
 Norway
3,381,831
3.002
0.09
 Poland
27,015,538
2.531
0.01
 Portugal
7,083,260
2.892
0.04
 Romania
15,224,032
1380
0.01
 Russian Federation
100,255,437
1.621
0.00
 Slovenia
1,365,999
200
0.01
 South Africa
31,673,647
566
0.00
 Spain
31,954,884
4.030
0.01
 Sweden
6,148,142
6.607
0.11
 Switzerland
5,427,608
4.167
0.08
 Turkey
55,288,903
6.347
0.01
 Ukraine
30,041,037
251
0.00
 United Kingdom
34,124,066
6.391
0.02
Total per area
611,438,662
154,494,00
0.03
Latin America
 Argentina
27,396,887
36.668
0.13
 Bolivia
13,125,128
314
0.00
 Brazil
139,204,011
97.480
0.07
 Chile
12,043,383
5.311
0.04
 Colombia
31,427,165
12.700
0.04
 Costa Rica
3,305,826
400
0.01
 Dominican Republic
6,722,618
1.117
0.02
 Ecuador
10,117,590
626
0.01
 Guatemala
8,735,638
200
0.00
 Mexico
78,705,142
2.500
0.00
 Paraguay
4,507,926
300
0.01
 Venezuela
19,024,145
4472
0.02
Total per area
354,315,459
162,088,00
0.05
Asia/Pacific
 Australia—New Zeland
17,957,192
14.966
0.08
 China
993,331,831
4.195
0.00
 Hong Kong
5,205,526
144
0.00
 India
812,335,761
11.336
0.00
 Iran
57,467,376
4.919
0.01
 Japan
77,538,543
222
0.00
 Korea
35,897,893
889
0.00
 Kuwait
1,983,536
5498
0.28
 Saudi Arabia
18,929,961
15.571
0.08
 Singapore
4,348,692
299
0.01
 Taiwan
34,593,332
2.421
0.01
 UAE
4,405,595
4.033
0.09
Total per area
2,063,995,238
64,493,00
0.00
Total
3,264,082,824
579,517,00
0.02
The significance of the value is specified in the first line of the table: it represents the percentage of bariatric procedures/total population (i.e. Among the Austrian population (5,525,965 people) were performed 2553 procedures that represents the 0.05%)
Therefore the accuracy of provided data is the major point of weakness of this survey. Only 35% of national societies had a national registry and most of the data were estimated. This flaw regards the entire database but may be more critical for the endoluminal therapies.
There have been five previous reports of the status of bariatric surgery worldwide [37]. All of them, as well as the current survey, were limited by the management and report of the data by the IFSO nations. The analysis of these data can never reach the accuracy and precision of a planned experiment or a clinical trial. However, this is the best achievable analysis of worldwide reported data. Despite these limits, worldwide surveys have always been a scientific landmark. The bariatric surgery community could not progress without a periodic collection and report of worldwide data. Results regarding the techniques of endoluminal bariatric surgery are extremely useful in the current scenario of modern bariatric armamentarium. The reported lack of response aims to be provocative. Data should absolutely be collected at national level by the IFSO societies.
In conclusion, national and international registries should be implemented and regularly updated taking into account all new endoscopic procedures that are continually evolving and will gain increasing importance in the near future. Moreover, further studies on large series of patients are mandatory to increase our knowledge of endoluminal procedures and to encourage the creation of specific international guidelines.

Acknowledgments

We thank Francesco Carignani and Manuela Mazzarella of IFSO Secretariat for their support.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.
This is a survey in which we do not directly involve human subjects; it is limited to an analysis of bariatric procedures performed around the world.

Statement of Human and Animal Rights

This is a survey in which we do not directly involve human subjects or animals; it is limited to an analysis of bariatric procedures performed around the world.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215-357, iii-iv doi:10.3310/hta13410. Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215-357, iii-iv doi:10.​3310/​hta13410.
2.
Zurück zum Zitat Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641. Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641.
3.
Zurück zum Zitat Scopinaro N. The IFSO and obesity surgery throughout the world. ObesSurg. 1998;8:3–8. Scopinaro N. The IFSO and obesity surgery throughout the world. ObesSurg. 1998;8:3–8.
4.
Zurück zum Zitat Buchwald H, Williams SE. Bariatric surgery worldwide 2003. ObesSurg. 2004;14:1157–64. Buchwald H, Williams SE. Bariatric surgery worldwide 2003. ObesSurg. 2004;14:1157–64.
12.
Zurück zum Zitat Diamantis T, Apostolou KG, Alexandrou A, Griniatsos J, Felekouras E, Tsigris C. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):177–183CrossRefPubMed Diamantis T, Apostolou KG, Alexandrou A, Griniatsos J, Felekouras E, Tsigris C. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis.​ 2014;10(1):177–183CrossRefPubMed
13.
Zurück zum Zitat Angrisani L, Santonicola A, Hasani A, et al. Five-year results of laparoscopic sleeve gastrectomy: effects on gastroesophageal reflux disease symptoms and co-morbidities. Surg Obes Relat Dis. 2016 12(5):960–8. doi:10.1016/j.soard.2015.09.014. Angrisani L, Santonicola A, Hasani A, et al. Five-year results of laparoscopic sleeve gastrectomy: effects on gastroesophageal reflux disease symptoms and co-morbidities. Surg Obes Relat Dis. 2016 12(5):960–8. doi:10.​1016/​j.​soard.​2015.​09.​014.
14.
Zurück zum Zitat Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001 Jun;11(3):276–80.CrossRefPubMed Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001 Jun;11(3):276–80.CrossRefPubMed
15.
Zurück zum Zitat Georgiadou D, Sergentanis TN, Nixon A, et al. Efficacy and safety of laparoscopic mini gastric bypass. A systematic review. Surg Obes Relat Dis. 2014;10:984–91. Georgiadou D, Sergentanis TN, Nixon A, et al. Efficacy and safety of laparoscopic mini gastric bypass. A systematic review. Surg Obes Relat Dis. 2014;10:984–91.
16.
Zurück zum Zitat Ponce J, Nguyen NT, Hutter M, et al. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011-2014. Surg Obes Relat Dis. 2015;11(6):1199–200. doi:10.1016/j.soard.2015.08.496. Ponce J, Nguyen NT, Hutter M, et al. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011-2014. Surg Obes Relat Dis. 2015;11(6):1199–200. doi:10.​1016/​j.​soard.​2015.​08.​496.
Metadaten
Titel
Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014
verfasst von
L. Angrisani
A. Santonicola
P. Iovino
A. Vitiello
N. Zundel
H. Buchwald
N. Scopinaro
Publikationsdatum
13.04.2017
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 9/2017
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2666-x

Weitere Artikel der Ausgabe 9/2017

Obesity Surgery 9/2017 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.